Emanuel F Petricoin Selected Research

Integrins

12/2020	Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
6/2013	Systems analysis of the NCI-60 cancer cell lines by alignment of protein pathway activation modules with "-OMIC" data fields and therapeutic response signatures.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emanuel F Petricoin Research Topics

Disease

129	Neoplasms (Cancer) 03/2022 - 01/2002
29	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2002
17	Carcinogenesis 01/2020 - 01/2002
16	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2002
14	Ovarian Neoplasms (Ovarian Cancer) 08/2017 - 07/2002
13	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2003
10	Carcinoma (Carcinomatosis) 07/2021 - 02/2002
8	Adenocarcinoma 01/2022 - 04/2003
8	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 02/2012
8	Melanoma (Melanoma, Malignant) 01/2021 - 10/2008
6	Lung Neoplasms (Lung Cancer) 10/2021 - 10/2015
6	Infections 01/2021 - 11/2010
5	Squamous Cell Carcinoma of Head and Neck 01/2022 - 02/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 10/2008
4	Disease Progression 01/2021 - 11/2003
4	Colorectal Neoplasms (Colorectal Cancer) 07/2017 - 06/2007
3	Triple Negative Breast Neoplasms 03/2022 - 01/2017
3	Pathologic Complete Response 03/2022 - 01/2018
3	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 02/2014
2	Tuberculosis (Tuberculoses) 09/2021 - 01/2020
2	Actinic Keratosis 01/2021 - 03/2012
2	Lyme Disease (Disease, Lyme) 11/2020 - 02/2011
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2018
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 11/2009
2	Fibrosis (Cirrhosis) 12/2018 - 01/2018
2	Non-alcoholic Fatty Liver Disease 12/2018 - 07/2007
2	Ovarian Epithelial Carcinoma 08/2017 - 01/2003
2	Skin Neoplasms (Skin Cancer) 11/2016 - 08/2015

Drug/Important Bio-Agent (IBA)

94	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2002
47	Biomarkers (Surrogate Marker)IBA 03/2022 - 07/2002
34	Pharmaceutical PreparationsIBA 01/2022 - 03/2004
23	Phosphotransferases (Kinase)IBA 11/2021 - 05/2005
15	PhosphoproteinsIBA 01/2022 - 02/2005
14	ProteomeIBA 01/2021 - 01/2002
7	Biological ProductsIBA 10/2021 - 11/2003
7	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 09/2011
7	Peptides (Polypeptides)IBA 11/2020 - 03/2004
7	ErbB Receptors (EGF Receptor)IBA 08/2020 - 10/2008
5	Lapatinib (GW572016)FDA Link 11/2019 - 11/2009
5	EnzymesIBA 01/2015 - 09/2004
4	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 08/2017
4	Hormones (Hormone)IBA 01/2022 - 03/2011
4	RNA (Ribonucleic Acid)IBA 07/2021 - 01/2003
4	Insulin (Novolin)FDA Link 01/2020 - 07/2007
4	TOR Serine-Threonine KinasesIBA 01/2019 - 04/2007
4	Transcription Factors (Transcription Factor)IBA 01/2018 - 09/2006
4	AntigensIBA 09/2016 - 06/2009
3	Epidermal Growth Factor (EGF)IBA 01/2022 - 01/2005
3	Trastuzumab (Herceptin)FDA Link 11/2021 - 07/2015
3	lipoarabinomannan (LAM)IBA 09/2021 - 12/2017
3	AntibodiesIBA 01/2021 - 01/2005
3	HydrogelsIBA 12/2020 - 02/2011
3	Estrogen ReceptorsIBA 08/2020 - 09/2006
3	Protein Kinases (Protein Kinase)IBA 01/2020 - 02/2011
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 10/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2003
3	Lactic Acid (Lactate)FDA LinkGeneric 07/2017 - 07/2012
3	Drug CombinationsIBA 06/2017 - 07/2015
3	Transforming Growth Factor beta (TGF-beta)IBA 12/2016 - 09/2003
3	Protein Isoforms (Isoforms)IBA 01/2015 - 01/2005
3	Pyruvate KinaseIBA 01/2015 - 11/2012
3	AlbuminsIBA 11/2011 - 01/2004
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2022 - 04/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 10/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 10/2021
2	AnthelminticsIBA 11/2021 - 02/2017
2	Metformin (Glucophage)FDA LinkGeneric 10/2021 - 10/2017
2	LigandsIBA 10/2021 - 11/2019
2	EpitopesIBA 09/2021 - 01/2020
2	BMS 754807IBA 01/2021 - 01/2020
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 11/2011
2	Blood Proteins (Serum Proteins)IBA 12/2020 - 01/2011
2	IntegrinsIBA 12/2020 - 06/2013
2	Complement System Proteins (Complement)IBA 12/2020 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 07/2015
2	MK 2206IBA 01/2020 - 01/2017
2	Androgen Receptors (Androgen Receptor)IBA 11/2019 - 01/2017
2	CollagenIBA 12/2018 - 05/2005
2	Toll-Like Receptor 4IBA 01/2018 - 11/2016
2	CytochromesIBA 10/2017 - 10/2017
2	BiguanidesIBA 10/2017 - 10/2017
2	Heme (Haem)IBA 10/2017 - 10/2017
2	Oxygen (Dioxygen)IBA 07/2017 - 07/2012
2	Phosphopyruvate Hydratase (Enolase)IBA 02/2016 - 06/2010
2	tyrosine receptor (receptor, tyrosine)IBA 10/2015 - 01/2015
2	Mitogen-Activated Protein KinasesIBA 01/2015 - 08/2009
2	Matrix Metalloproteinases (MMPs)IBA 10/2014 - 05/2013
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2012 - 07/2012
2	Glutamine (L-Glutamine)FDA Link 11/2012 - 02/2012
2	MitogensIBA 03/2012 - 02/2011

Therapy/Procedure

54	Therapeutics 01/2022 - 08/2002
23	Lasers (Laser) 10/2021 - 02/2002
8	Precision Medicine 10/2021 - 05/2010
6	Drug Therapy (Chemotherapy) 08/2020 - 11/2009
3	Neoadjuvant Therapy 10/2021 - 02/2007
3	Immunotherapy 01/2021 - 06/2009
3	Molecular Targeted Therapy 02/2011 - 03/2005
2	Radiotherapy 01/2022 - 01/2018
2	Oral Administration 11/2021 - 01/2017
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 04/2007